CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

ArsenalBio sacrifices ‘majority’ of staff in pivot to in vivo CAR T

Negative
AI Analysis

Summary

ArsenalBio is laying off 99 employees as part of a strategic pivot to focus R&D efforts on in vivo CAR T therapies, following a 50% workforce reduction the previous year.

Importance:3/10
Sentiment:
-0.80
layoffrestructuringCAR TR&D pivot

Read the original article

Published by BioSpace on September 1, 2026 12:20 PM

Read Original